Startup India Government of India
Tournef Pharmaceuticals Private Limited
Tournef Pharmaceuticals Private Limited - chemicals and materials in Dewas, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹99.39 Lakh
▲ 113% YoY
Net profit · FY 2025
₹1.16 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹11.58 Lakh
EBITDA margin 11.7%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹86.8 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Tournef Pharmaceuticals Private Limited
Data last updated:
Tournef Pharmaceuticals Private Limited is a private limited company based in Dewas, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 10 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2020PTC050919. Its GSTIN is 23AAHCT7611E1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Sodan Singh Chouhan and Aarti Pavar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 297 Mig Sector D New Dewas – 455001 Madhya Pradesh India, Madhya Pradesh, India – 455001.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.39 Lakh, a growth of 113% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 1.2%) and EBITDA of ₹11.58 Lakh (EBITDA margin 11.7%).
As per MCA filings, the company has open charges of ₹86.8 Lakh on record.
Tournef Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-16-0010755).
Company details
CIN U24299MP2020PTC050919
Registration Number 050919
Incorporation Date 10 February 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MP-16-0010755
Key People
Sodan Singh Chouhan Director Aarti Pavar Director Recognitions & Rankings of Tournef Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-16-0010755
Contact details
Tournef Pharmaceuticals Private Limited's registered office is in Dewas, Madhya Pradesh.
- Registered Address297 Mig Sector D New Dewas – 455001 Madhya Pradesh India, Madhya Pradesh, India – 455001
- IndustryChemicals and Materials, Industrial Chemicals
Comprehensive company report
Tournef Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Tournef Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tournef Pharmaceuticals Private Limited, buy the company report.
Financials of Tournef Pharmaceuticals Private Limited
FY 2025 filings availableTournef Pharmaceuticals Private Limited reported revenue of ₹99.39 Lakh (up 113% YoY) for FY 2025.
Revenue · FY 2025
₹99.39 Lakh ▲ 113%
Net profit · FY 2025
₹1.16 Lakh margin 1.2%
EBITDA · FY 2025
₹11.58 Lakh margin 11.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 113%
EBITDA CAGR growth
1 year
▲ 430%
Revenue rose 113% in the latest year. EBITDA rose 430% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.7% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tournef Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tournef Pharmaceuticals Private Limited
Tournef Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sodan Singh Chouhan | Director | 10 Feb 2020 | 6 Years 9 Months | Current |
| Aarti Pavar | Director | 10 Feb 2020 | 6 Years 9 Months | Current |
Charges & borrowings
Open charges
₹86.8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Sep 2022 | 100656104 | Others | ₹86.8 Lakh | Open |
To see the full charge records of Tournef Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Tournef Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tournef Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tournef Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCT7611E1ZL | Madhya Pradesh | Active | 28 Jul 2020 |
To see the full GST registrations and return filing status of Tournef Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tournef Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Aarti Pavar was appointed as Director on 10 Feb 2020.
AGM
Tournef Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tournef Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others of Rs. 86.80 Lakh registered on 05 Sep 2022 with Charge ID 100656104 was modified on 31 Jan 2025.
Charges
A charge with Others amounted to Rs. 86.80 Lakh with Charge ID 100656104 was registered on 05 Sep 2022.
Appointed
Aarti Pavar was appointed as Director.
Appointed
Sodan Singh Chouhan was appointed as Director.
Incorporation
10 Feb 2020
Tournef Pharmaceuticals Private Limited was registered on 10 Feb 2020 with Roc Gwalior & aged 6 years 9 months as per MCA records.
Frequently asked questions
Tournef Pharmaceuticals is an active private limited company based in Dewas, Madhya Pradesh, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 10 February 2020 (6+ years old) and is registered under CIN U24299MP2020PTC050919.
Tournef Pharmaceuticals has 2 current directors:
- Sodan Singh Chouhan - Director
- Aarti Pavar - Director
The latest financial statements of Tournef Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Tournef Pharmaceuticals is 23AAHCT7611E1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Tournef Pharmaceuticals is U24299MP2020PTC050919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tournef Pharmaceuticals was incorporated on 10 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
Aarti Pavar was appointed as Director on 10 Feb 2020. Sodan Singh Chouhan was appointed as Director on 10 Feb 2020.
Yes, Tournef Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Tournef Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-16-0010755).
The registered office of Tournef Pharmaceuticals is at 297 Mig Sector D New Dewas – 455001 Madhya Pradesh India, Madhya Pradesh, India – 455001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages